Mika Hirasawa-Fujita

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder

Mika Hirasawa-Fujita, Michael J. Bly, Vicki L. Ellingrod et al. · Clinical Schizophrenia & Related Psychoses · 2017 · 36 citations · Full text

Medicine, Psychiatry, Neurogenetics +14

Regional brain [ 11 C]carfentanil binding following tobacco smoking

Edward F. Domino, Mika Hirasawa-Fujita, Lisong Ni et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2015 · 24 citations · Full text

Life Sciences, Neuroscience, Pharmacology +13

Cortisol in schizophrenia: No association with tobacco smoking, clinical symptoms or antipsychotic medication

Gordana Nedić Erjavec, Suzana Uzun, Matea Nikolac Perković et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2017 · 23 citations · Full text

Medicine, Pharmacology, Psychiatry +11

Direct electron transfer from pseudoazurin to nitrous oxide reductase in catalytic N2O reduction

Koyu Fujita, Mika Hirasawa-Fujita, Doreen E. Brown et al. · Journal of Inorganic Biochemistry · 2012 · 21 citations

Natural Sciences, Biochemistry, Chemistry +16

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder

Mika Hirasawa-Fujita, Michael J. Bly, Vicki L. Ellingrod et al. · Clinical Schizophrenia & Related Psychoses · 2014 · 12 citations

Medicine, Psychiatry, Neurogenetics +14